All NewsFDA BriefsOncology IconsSpecial ReportsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision MedicineSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

A 61-Year-Old Man With Stage 4 Hepatocellular Carcinoma

home / case-based-peer-perspectives / a-61-year-old-man-with-stage-4-hepatocellular-carcinoma

Pierre Gholam, MD, provides insight on the case of a 61-year-old man with stage 4 hepatocellular carcinoma and evaluates current treatment options on TKIs.

61-Year-Old Man With Stage IV Hepatocellular Carcinoma

EP. 1: 61-Year-Old Man With Stage IV Hepatocellular Carcinoma

Pierre Gholam, MD
June 24th 2020

Watch

Patient Prognosis of Metastatic HCC

EP. 2: Patient Prognosis of Metastatic HCC

Pierre Gholam, MD
June 24th 2020

Watch

Multidisciplinary Management and Diagnostic Work-up of HCC

EP. 3: Multidisciplinary Management and Diagnostic Work-up of HCC

Pierre Gholam, MD
June 24th 2020

Watch

Frontline Treatment in HCC: Systemic vs Locoregional Therapy

EP. 4: Frontline Treatment in HCC: Systemic vs Locoregional Therapy

Pierre Gholam, MD
June 24th 2020

Watch

Advanced HCC: IMbrave150 Trial

EP. 5: Advanced HCC: IMbrave150 Trial

Pierre Gholam, MD
June 24th 2020

Watch

Approaching Second-Line Therapy for Advanced HCC

EP. 6: Approaching Second-Line Therapy for Advanced HCC

Pierre Gholam, MD
June 24th 2020

Watch

Advanced HCC: CELESTIAL Trial

EP. 7: Advanced HCC: CELESTIAL Trial

Pierre Gholam, MD
June 24th 2020

Watch

Future Treatment Landscape for Advanced HCC

EP. 8: Future Treatment Landscape for Advanced HCC

Pierre Gholam, MD
June 24th 2020

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2024 MJH Life Sciences

All rights reserved.